Quest for the right Drug

|
עמוד הבית / רט-אויט ג'ל % 0.025 / מידע מעלון לרופא

רט-אויט ג'ל % 0.025 RET-AVIT GEL 0.025 % (TRETINOIN)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

עורי : DERMAL

צורת מינון:

ג'ל : GEL

Posology : מינונים

4.2   Posology and method of administration

RET-AVIT is for cutaneous use only.

The generally accepted dosage is: lightly apply to the entire affected area once a day in the evening before bedtime. For people with light or sensitive skin, it is recommended to apply the preparation once a day or every other day, depending on how the skin reacts.

Do not exceed the recommended dose

Do not swallow. For external use only.
Before treatment, you should clean the skin with lukewarm water and/or gentle soap, dry the skin gently without rubbing it and wait for 20-30 minutes before applying the medicine. Do not wash the treated area more than twice per day.
Wash your hands after the treatment.

Apply a small amount of RET-AVIT and cover only the affected areas. You can use cotton wool or clean cotton swabs. Avoid accumulation of too much RET- AVIT in skin folds, such as the area where the nose meets the face. Do not apply to a cracked or eczematous area, to the eyes, eyelids, nostrils or mouth.

If RET-AVIT comes into contact with these areas, wash them thoroughly with water.

Duration of treatment – the results of the treatment are visible after two to three weeks, but it may take six to eight weeks to achieve maximum results. The minimal duration of treatment is three months.

After applying of RET-AVIT, the skin may feel warm or sting slightly for a while.
If these sensations continue or become worse, consult your doctor.

A transitory feeling of warmth or slight stinging may be noted on application.

Patients treated with RET-AVIT may use cosmetics, but the areas to be treated should be cleansed thoroughly before the medication is applied. Astringent toiletries should be avoided.

Children
Use of RET-AVIT in children under 10 years of age has not been investigated.

Elderly
Safety and effectiveness in a geriatric population have not been established.
Clinical studies of RET-AVIT did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.

שימוש לפי פנקס קופ''ח כללית 1994 Acne. יירשם ע"י רופא עור
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת

רישום

060 21 27045 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

28.03.21 - עלון לרופא

עלון מידע לצרכן

28.03.21 - עלון לצרכן אנגלית 28.03.21 - עלון לצרכן עברית 28.03.21 - עלון לצרכן ערבית 28.03.21 - החמרה לעלון 24.06.13 - החמרה לעלון

לתרופה במאגר משרד הבריאות

רט-אויט ג'ל % 0.025

קישורים נוספים

RxList WebMD Drugs.com